Ajanta Pharma advances on launching Eletriptan Hydrobromide Tablets in US

31 Aug 2017 Evaluate

Ajanta Pharma is currently trading at Rs. 1199.30, up by 6.35 points or 0.53% from its previous closing of Rs. 1192.95 on the BSE.

The scrip opened at Rs. 1197.00 and has touched a high and low of Rs. 1225.05 and Rs. 1194.60 respectively. So far 19,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2150.00 on 28-Oct-2016 and a 52 week low of Rs. 1106.00 on 22-Aug-2017.

Last one week high and low of the scrip stood at Rs. 1249.00 and Rs. 1188.75 respectively. The current market cap of the company is Rs. 10,554.56 crore.

The promoters holding in the company stood at 73.78%, while Institutions and Non-Institutions held 13.81% and 12.41% respectively.

Ajanta Pharma has launched Eletriptan Hydrobromide Tablets in the US market through its wholly owned subsidiary Ajanta Pharma USA. It is a bioequivalent generic version of Relpax Tablets. The company has launched the product in two strengths, 20 mg and 40 mg tablets.

Eletriptan Hydrobromide Tablets is part of an ever growing portfolio of products that Ajanta has developed for the US market. In total, Ajanta has 35 Abbreviated New Drug Applications (ANDAs) of which it has 19 final ANDA approvals, 2 tentative approvals, and 14 ANDAs under review with US FDA. So far it has launched 14 products in the US market.

Ajanta Pharma is a speciality pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.


Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×